ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)
Technological and Clinical Innovative Protocols for the Production of Functional Foods - 6.7 (ProAliFun67)
1 other identifier
interventional
57
1 country
1
Brief Summary
The purpose of this clinical study is to evaluate the health properties of a dietary intervention carried on with an innovative low-salt bread. The hypothesis is that the introduction of a low-sodium bread as part of a low-salt diet may improve the compliance to the own regime and that the vascular function, the inflammatory and oxidative state, the composition of the intestinal microbiota and that neurocognitive and neurodegenerative processes can improve in hypertensive patients fed a low-salt diet with low-salt bread.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Dec 2014
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 10, 2017
CompletedFirst Posted
Study publicly available on registry
April 25, 2017
CompletedApril 25, 2017
April 1, 2017
6 months
April 10, 2017
April 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sodium intake
Reduction of sodium intake in diet with the introduction of the innovative formulation of low-salt bread
6 months
Secondary Outcomes (6)
Blood pressure
6 months
Endothelial stress
6 months
Gut microbiota
6 months
Antioxidant status
6 months
Inflammation
6 months
- +1 more secondary outcomes
Study Arms (3)
A - control
NO INTERVENTIONFree diet with standard bread
B - low-salt diet with normal bread
ACTIVE COMPARATORLow-sodium diet with standard bread
C - low-salt diet with low-salt bread
EXPERIMENTALLow-sodium diet with low-sodium bread
Interventions
low-sodium diet (2300 mg Na/die) with use of standard bread (750 mg Na/100g) for 6 months
low-sodium diet (2300 mg Na/die) with use of low-salt bread (280 mg Na/100g) for 6 months
Eligibility Criteria
You may qualify if:
- arterial hypertension stage I-II
- stable control of blood pressure
- eGFR \> 60
- informed consent signed
You may not qualify if:
- uncontrolled hypertension
- therapy with diuretics
- need for therapy with more than three antihypertensive drugs
- proteinuria greater than 1 g/day
- celiac disease
- systemic inflammatory diseases
- suspicion or clinical diagnosis of malignancy
- chronic liver disease
- treatment with corticosteroids or immunosuppressive drugs
- previous acute cardiovascular diseases (myocardial infarction, stroke)
- psychiatric conditions reducing the compliance to treatment protocols
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AUO Policlinico Consorziale
Bari, BA, 70125, Italy
Related Publications (1)
Cosola C, Pesce F, De Angelis M, Maranzano V, Zito A, Montemurno E, Dalfino G, Loiudice S, Creanza V, Pompa G, Ciccone MM, Grandaliano G, Stallone G, Gesualdo L. Effects of low-sodium bread on dietary compliance and fecal cultivable bacteria in a randomized controlled pilot trial in hypertensive subjects. BMC Nutr. 2024 Feb 21;10(1):31. doi: 10.1186/s40795-024-00838-w.
PMID: 38383476DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Loreto Gesualdo, MD Full Prof
Head of the Nephrology, Dialysis and Transplantation Unit "Aldo Moro" University of Bari Azienda Ospedaliero-Universitaria Consorziale "Policlinico"
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2017
First Posted
April 25, 2017
Study Start
December 1, 2014
Primary Completion
June 1, 2015
Study Completion
August 1, 2015
Last Updated
April 25, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share